Landscapes / Companies
Applied Biology, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
2 in Phase 2
Drugs
5
in active trials · 8 in all
Trials
5 active
12 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 19 Mar 2027Phase 2/3 trial completes | |||
| Next date | 19 Mar 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Telogen Effluvium, Female Pattern Hair Loss and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 15 Dec 2027Phase 3 trial completes | |||
| Next date | 15 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Canities, Grey Hair | ||||
| Open drug page | |||||
— |
Phase 3 | 11 Mar 2028Phase 3 trial completes | |||
| Next date | 11 Mar 2028 · Phase 3 trial completes | ||||
| Also tested for | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | ||||
| Open drug page | |||||
— |
Phase 1/2 | 5 Feb 2027Phase 1/2 trial completes | |||
| Next date | 5 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | ||||
| Open drug page | |||||
— |
Phase 1/2 | 15 Oct 2027Phase 1/2 trial completes | |||
| Next date | 15 Oct 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Canities, Grey Hair | ||||
| Open drug page | |||||
About
- No active trial
- DA-002, HC-1119, Proxalutamide
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021